243 related articles for article (PubMed ID: 15860969)
1. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
Abraham WT; Cheng ML; Smoluk G;
Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969
[TBL] [Abstract][Full Text] [Related]
2. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
[TBL] [Abstract][Full Text] [Related]
3. Nesiritide: a review of its use in acute decompensated heart failure.
Keating GM; Goa KL
Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
Elkayam U; Akhter MW; Singh H; Khan S; Usman A
Am J Cardiol; 2004 Jan; 93(2):237-40. PubMed ID: 14715359
[TBL] [Abstract][Full Text] [Related]
5. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
[TBL] [Abstract][Full Text] [Related]
6. Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy.
Peacock WF; Emerman CL; Young J
J Card Fail; 2004 Apr; 10(2):120-5. PubMed ID: 15101023
[TBL] [Abstract][Full Text] [Related]
7. Nesiritide for the treatment of congestive heart failure.
Iyengar S; Feldman DS; Trupp R; Abraham WT
Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of nesiritide for the treatment of decompensated heart failure.
Emerman CL
Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428
[TBL] [Abstract][Full Text] [Related]
9. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
[TBL] [Abstract][Full Text] [Related]
10. Nesiritide: a new therapy for the treatment of heart failure.
Maisel AS
Cardiovasc Toxicol; 2003; 3(1):37-42. PubMed ID: 12668889
[TBL] [Abstract][Full Text] [Related]
11. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.
Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K
J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005
[TBL] [Abstract][Full Text] [Related]
12. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
[TBL] [Abstract][Full Text] [Related]
13. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
[TBL] [Abstract][Full Text] [Related]
14. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Rifkin W
JAMA; 2002 Aug; 288(5):572; author reply 572-3. PubMed ID: 12150662
[No Abstract] [Full Text] [Related]
15. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure.
Butler J; Emerman C; Peacock WF; Mathur VS; Young JB;
Nephrol Dial Transplant; 2004 Feb; 19(2):391-9. PubMed ID: 14736964
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
[TBL] [Abstract][Full Text] [Related]
17. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure.
Peacock WF; Emerman CL; Silver MA
Am J Emerg Med; 2005 May; 23(3):327-31. PubMed ID: 15915407
[TBL] [Abstract][Full Text] [Related]
18. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Dunavant S
JAMA; 2002 Aug; 288(5):571-2; author reply 572-3. PubMed ID: 12150661
[No Abstract] [Full Text] [Related]
19. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
[TBL] [Abstract][Full Text] [Related]
20. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
